169 related articles for article (PubMed ID: 17991539)
1. High yield of saturation prostate biopsy for patients with previous negative biopsies and small prostates.
Sajadi KP; Kim T; Terris MK; Brown JA; Lewis RW
Urology; 2007 Oct; 70(4):691-5. PubMed ID: 17991539
[TBL] [Abstract][Full Text] [Related]
2. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
[TBL] [Abstract][Full Text] [Related]
3. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
4. Is race a positive predictor of cancer on repeat prostate biopsy?
Yanke BV; Salzhauer EW; Colon I
J Urol; 2006 Sep; 176(3):1114-7. PubMed ID: 16890704
[TBL] [Abstract][Full Text] [Related]
5. Prostate cancers diagnosed at repeat biopsy are smaller and less likely to be high grade.
Tan N; Lane BR; Li J; Moussa AS; Soriano M; Jones JS
J Urol; 2008 Oct; 180(4):1325-9; discussion 1329. PubMed ID: 18707706
[TBL] [Abstract][Full Text] [Related]
6. The effect of prostate volume on the yield of needle biopsy.
Letran JL; Meyer GE; Loberiza FR; Brawer MK
J Urol; 1998 Nov; 160(5):1718-21. PubMed ID: 9783939
[TBL] [Abstract][Full Text] [Related]
7. High incidence of prostate cancer detected by saturation biopsy after previous negative biopsy series.
Walz J; Graefen M; Chun FK; Erbersdobler A; Haese A; Steuber T; Schlomm T; Huland H; Karakiewicz PI
Eur Urol; 2006 Sep; 50(3):498-505. PubMed ID: 16631303
[TBL] [Abstract][Full Text] [Related]
8. Intensifying the saturation biopsy technique for detecting prostate cancer after previous negative biopsies: a step in the wrong direction.
Simon J; Kuefer R; Bartsch G; Volkmer BG; Hautmann RE; Gottfried HW
BJU Int; 2008 Aug; 102(4):459-62. PubMed ID: 18325061
[TBL] [Abstract][Full Text] [Related]
9. Extensive biopsies and transurethral prostate resection in men with previous negative biopsies and high or increasing prostate specific antigen.
Ploussard G; Dubosq F; Boublil V; Allory Y; de la Taille A; Vordos D; Hoznek A; Abbou CC; Salomon L
J Urol; 2009 Oct; 182(4):1342-9. PubMed ID: 19683310
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer detection rate in patients with repeated extended 21-sample needle biopsy.
Campos-Fernandes JL; Bastien L; Nicolaiew N; Robert G; Terry S; Vacherot F; Salomon L; Allory Y; Vordos D; Hoznek A; Yiou R; Patard JJ; Abbou CC; de la Taille A
Eur Urol; 2009 Mar; 55(3):600-6. PubMed ID: 18597923
[TBL] [Abstract][Full Text] [Related]
11. Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
Capitanio U; Karakiewicz PI; Valiquette L; Perrotte P; Jeldres C; Briganti A; Gallina A; Suardi N; Cestari A; Guazzoni G; Salonia A; Montorsi F
Urology; 2009 May; 73(5):1087-91. PubMed ID: 19195695
[TBL] [Abstract][Full Text] [Related]
12. The impact of obesity on the diagnosis of prostate cancer using a modern extended biopsy scheme.
Pruthi RS; Swords K; Schultz H; Carson CC; Wallen EM
J Urol; 2009 Feb; 181(2):574-7; discussion 578. PubMed ID: 19084847
[TBL] [Abstract][Full Text] [Related]
13. Prebiopsy PSA velocity not reliable predictor of prostate cancer diagnosis, Gleason score, tumor location, or cancer volume after TTMB.
Bittner N; Merrick GS; Andreini H; Taubenslag W; Allen ZA; Butler WM; Anderson RL; Adamovich E; Wallner KE
Urology; 2009 Jul; 74(1):171-6. PubMed ID: 19232691
[TBL] [Abstract][Full Text] [Related]
14. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.
Pepe P; Aragona F
Urology; 2007 Dec; 70(6):1131-5. PubMed ID: 18158033
[TBL] [Abstract][Full Text] [Related]
15. Saturation prostate biopsy in high risk patients after multiple previous negative biopsies.
Stav K; Leibovici D; Sandbank J; Lindner A; Zisman A
Urology; 2008 Mar; 71(3):399-403. PubMed ID: 18342172
[TBL] [Abstract][Full Text] [Related]
16. Use of extended pattern technique for initial prostate biopsy.
Siu W; Dunn RL; Shah RB; Wei JT
J Urol; 2005 Aug; 174(2):505-9. PubMed ID: 16006881
[TBL] [Abstract][Full Text] [Related]
17. Extended 21-sample needle biopsy protocol for diagnosis of prostate cancer in 1000 consecutive patients.
Guichard G; Larré S; Gallina A; Lazar A; Faucon H; Chemama S; Allory Y; Patard JJ; Vordos D; Hoznek A; Yiou R; Salomon L; Abbou CC; de la Taille A
Eur Urol; 2007 Aug; 52(2):430-5. PubMed ID: 17412489
[TBL] [Abstract][Full Text] [Related]
18. MRI-guided biopsy of the prostate increases diagnostic performance in men with elevated or increasing PSA levels after previous negative TRUS biopsies.
Anastasiadis AG; Lichy MP; Nagele U; Kuczyk MA; Merseburger AS; Hennenlotter J; Corvin S; Sievert KD; Claussen CD; Stenzl A; Schlemmer HP
Eur Urol; 2006 Oct; 50(4):738-48; discussion 748-9. PubMed ID: 16630688
[TBL] [Abstract][Full Text] [Related]
19. Prostate cancer detection with office based saturation biopsy in a repeat biopsy population.
Rabets JC; Jones JS; Patel A; Zippe CD
J Urol; 2004 Jul; 172(1):94-7. PubMed ID: 15201745
[TBL] [Abstract][Full Text] [Related]
20. Prostate volume and pathologic prostate cancer outcomes after radical prostatectomy.
Pierorazio PM; Kinnaman MD; Wosnitzer MS; Benson MC; McKiernan JM; Goluboff ET
Urology; 2007 Oct; 70(4):696-701. PubMed ID: 17991540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
